Clinical trial
Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial…
NCT00409942 · Ferrer Internacional S.A., Industry · Completed
Key facts
| NCT number | NCT00409942 |
|---|---|
| Title | Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure. |
| Official title | Prospective, Randomised, Open, Blinded-endpoint Study of Torasemide Prolonged Release vs Furosemide to Evaluate the Efficacy on Myocardial Fibrosis in Patients With Heart Failure |
| Acronym | TORAFIC |
| Lead sponsor | Ferrer Internacional S.A., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure |
| Intervention type | Drug |
| Interventions | Torasemide Prolonged Release, Furosemide |
| Enrollment | 142 |
| Start date | Mar 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Dec 12, 2006 |
| Last update posted | Jul 15, 2009 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: